Sage Therapeutics
SAGE
#7053
Rank
A$0.81 B
Marketcap
A$12.99
Share price
0.00%
Change (1 day)
-0.09%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -A$0.47 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are A$70.41 Million. In 2024 the company made an earning of -A$0.6 Billion, an increase over its 2023 earnings that were of -A$0.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.47 Billion-22.52%
2024 -A$0.6 Billion-26.01%
2023 -A$0.82 Billion1.63%
2022 -A$0.8 Billion16.36%
2021 -A$0.69 Billion-175.55%
2020 A$0.90 B-189.1%
2019 -A$1.02 Billion82.43%
2018 -A$0.56 Billion38.04%
2017 -A$0.41 Billion69.9%
2016 -A$0.24 Billion68.25%
2015 -A$0.15 Billion179.48%
2014 -A$50.59 Million84.98%
2013 -A$27.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-A$70.96 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
A$53.34 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
A$0.76 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-A$86.79 Million-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA